ABSTRACT
Objective:To investigate the safety and clinical outcome of ultra-early oral nutrition after endoscopic treatment of gastroesophageal variceal bleeding in liver cirrhosis patients.Methods:Cirrhotic patients with gastroesophageal variceal bleeding who received endoscopic treatment at the Endoscopic Center of Beijing Haidian Hospital were retrospectively included from January 2018 to January 2022. The patients were divided into ultra-early oral nutrition group where patients would fast for 4 hours after endoscopic treatment and routine treatment group where patients would fast for at least 48 hours after operation and receive parenteral nutrition during fasting. The rebleeding, infection events (including pulmonary infection, urinary infection, spontaneous bacterial peritonitis, etc.), hospitalization duration and hospital readmission were recorded and compared between the two groups.Results:A total of 96 patients were enrolled, including 52 with ultra-early oral nutrition, 44 with routine treatment. There was no significant difference in age, gender, BMI, cause of liver cirrhosis, Child-Pugh score, LDRf classification of gastroesophageal varices and degree of esophageal varices between the two groups ( P > 0.05). All patients were followed up for 6 weeks and there was no significant difference in incidence of rebleeding (5.8% vs 4.5%, P > 0.999), peritonitis (1.9% vs 4.5%, P = 0.883), pulmonary infection (5.8% vs 11.4%, P = 0.537) and urinary infection (3.8% vs 2.3%, P > 0.999) between the two groups. The non-inferiority analysis suggested that the safety defined as free from rebleeding in ultra-early oral nutrition group was not inferior to that in routine treatment group ( P = 0.0018). The hospitalization duration in ultra-early oral nutrition group was significantly shorter than that in routine treatment group (6 days vs 9 days, P < 0.001). The hospital readmission rate within 6 weeks in the ultra-early oral nutrition group tended to be lower than that in the routine treatment group (3.8% vs 9.1%, P = 0.526). Conclusion:Ultra-early oral nutrition after endoscopic treatment of gastroesophageal variceal bleeding in liver cirrhosis patients shows similar rebleeding risk compared with current practice and can shorten hospitalization duration.
ABSTRACT
Resumen Objetivo: Determinar si la nutrición vía oral precoz (NVOP) disminuye la estancia hospitalaria y no se asocia a mayor reactivación de pancreatitis aguda (PA), ni a deterioro del pronóstico. Materiales y Método: Cohorte prospectiva de pacientes con PA, a los cuales se les aplicó un protocolo de NVOP y se evaluó tolerancia, tiempo de realimentación, estancia hospitalaria, reactivación de PA, complicaciones locales y necesidad de cama en unidad de cuidado crítico. Comparamos resultados entre pacientes que toleraron y no toleraron dicho protocolo. Resultados: Incluimos 65 pacientes, 69,2% de género femenino. El 49,3% presentó pancreatitis aguda grave (PAG) y 90,8% toleró protocolo de NVOP, con promedio de estancia hospitalaria de 13,3 ± 5 días vs. 19 ± 8,2 días en quienes no toleraron (p = 0,0177). Hubo reactivación de PA en 1 (1,5%) paciente sin tener relación con el protocolo. No hubo necesidad de cama UTI/UCI, ni mortalidad. Nueve pacientes fueron excluidos por no cumplir criterios para iniciar o mantener protocolo. Discusión: La PA es motivo frecuente de consulta en los servicios de urgencia de nuestro país, por lo que lograr una estandarización en la terapia nutricional resulta de mucha importancia para disminuir la morbimortalidad. Nuestros resultados son comparables con estudios internacionales que apoyan la nutrición enteral precoz. Conclusión: La tolerancia a la NVOP en el tratamiento de la PA, se asocia a menor estancia hospitalaria, menor tasa de reactivación de PA, menos complicaciones locales y sin aumentar la mortalidad, en relación con los que no toleran la NVOP.
Aim: To determínate if the tolerance to early oral nutrition (NVOP) decreases hospital stay and is not associated with greater reactivation of acute pancreatitis (AP) or worst prognosis compared to patients that did not tolerate NVOP protocol. Materials and Method: A prospective cohort of patients with AP who NVOP protocol was applied then we evaluated protocol tolerance, feedback time, hospital stay, AP reactivation, presence of local complications, and need for bed in critical care unit. The results were compared between patients who tolerate and did not tolerate this protocol. Results: 65 patients were included, 69.2% female. 49.3% presented severe acute pancreatitis (PAG) and 90.8% tolerated the NVOP protocol, with a mean hospital stay of 13.3 ± 5 days vs. 19 ± 8.2 days in those who did not tolerate it (p = 0,0177). There was reactivation of AP in 1 (1.5%) patient without relation to the protocol. Nine patients were excluded, because they did not achieve criteria to start or maintain protocol. Discussion: The AP is a frequent reason for consultation in the emergency services of our country, so achieving standardization in nutritional therapy is of great importance to reduce morbidity and mortality. Our results are comparable with international studies supporting early enteral nutrition. Conclusion: The tolerance to NVOP as treatment of AP it is associated with shorter hospital stay, and is not related to a higher rate of reactivation of AP, local complications, or increased mortality compared to the patients who did not tolerate this protocol.
Subject(s)
Humans , Male , Female , Pancreatitis/therapy , Acute Disease , Nutritional Status , Cohort Studies , Treatment Outcome , Risk AssessmentABSTRACT
Abstract Background Intradialytic oral nutrition (ION) has been shown to improve many clinical outcomes, including lowering mortality, in hemodialysis (HD) patients. Despite the benefits, ION is underused in many countries. Objective The objective of our study was to determine the perception of health-care professionals (HCP) in our environment of the use of ION in patients undergoing HD. Methods Survey applied to HCP in Mexico who worked or had worked in an HD unit in their locality. Results From 272 HCP who answered the survey, 74.3% believed that the use of ION has at least one beneficial effect; of these, the most frequently mentioned were an improvement in quality of life (QoL) (54.7%) followed by an improvement in serum albumin (37.9%) and muscle anabolism (31.6%). However, 49% consider that its use involves some risks. Of the respondents, 22% reported that their HD units allowed patients to consume food or supplements during HD sessions; the main reason given to forbid the introduction of food or supplements was the clinics policy (41%). Conclusions The personnel surveyed heterogeneous opinions regarding ION, but most believe that it may improve the QoL or the nutritional status of the patients. Nevertheless, the use of ION is uncommon in our country as it is against the internal regulations of most HD units.
Subject(s)
Humans , Child , Adult , Nutritional Status , Renal Dialysis/methods , Health Personnel/statistics & numerical data , Dietary Supplements , Quality of Life , Serum Albumin/analysis , Attitude of Health Personnel , Cross-Sectional Studies , Surveys and Questionnaires , MexicoABSTRACT
The benefits of preoperative oral carbohydrate drink have been confirmed,which have been approved and recommended by many guidelines.It was used most widely in the theory of ERAS(Enhanced Recovery After Surgery).The smooth implementation requires the good cooperation of surgeons,anesthesiologists and other medical staff.In this paper,the origin,development,status quo,function and its mechanism,controversy and future research of preoperative oral carbohydrate drink were reviewed.
ABSTRACT
Objective: To observe the clinical effect of oral nutrition supplementation for maxillofacial tumor patients before operation. Methods: 60 patients who suffered from maxillofacial neoplasm were divided into two groups. In observation group, on basis of routine diet, oral nutrition supplements (Fortisip) had been added for 5～7 days before operation. In control group, only routine diet had been supplied. After operation, the two groups were all supplied with tube feeding. The blood routine test, plasma total protein, albumin, pre albumin and lymphocyte count were measured in all patients. Results: Every biochemical item reduced significantly after operation and no statistical significance was found between groups. But the absolute decreasing values had significant difference between the groups. Conclusions: Oral nutrition supplements (Fortisip) contains balanced nutrients and tastes well. It is safe and effective to use a nutritional supplement, being helpful to prevent malnutrition and to improve the immune function in perioperative period of patients with maxillofacial neoplasm.